Recently, two more potent inhibitors of USP7 have been identified, and one of them, FT671, has been shown to destabilize HDM2, increase levels of p53 and transcription of p53 target genes, and inhibit tumour growth in mice (Turnbull et al., 2017). The gene discussed is TP53; the disease is neoplasm.